Market revenue in 2023 | USD 675.2 million |
Market revenue in 2030 | USD 1,322.6 million |
Growth rate | 10.1% (CAGR from 2023 to 2030) |
Largest segment | Off-pump |
Fastest growing segment | Minimally Invasive Direct |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Off-Pump, On-Pump, Minimally Invasive Direct |
Key market players worldwide | Medtronic PLC, Terumo Corp, Boston Scientific Corp, Getinge AB ADR, Karl Storz, Edwards Lifesciences Corp, LivaNova PLC, Novadaq Technologies, Genesee BioMedical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to coronary artery bypass graft market will help companies and investors design strategic landscapes.
Off-pump was the largest segment with a revenue share of 83.59% in 2023. Horizon Databook has segmented the Japan coronary artery bypass graft market based on off-pump, on-pump, minimally invasive direct covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan coronary artery bypass graft market , including forecasts for subscribers. This country databook contains high-level insights into Japan coronary artery bypass graft market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account